Severe COVID-19 infection and its unexpected impact on cancer

A study sheds light on a surprising aspect of severe COVID-19. According to its findings, severe infection could activate an immune response capable of reducing the size of cancerous tumors. Performed on mice, the study shows that the body produces "induced" monocytes, trained to fight the SARS-CoV-2 virus while retaining the ability to target and attack cancer cells.